Jefferson Anesthesia Conference 2024

Saturday, February 3, 2024, 4:00 PM - Thursday, February 8, 2024, 7:30 PM, Other, Big Sky, MT


AMA PRA Category 1 Credits™ (25.00 hours), ABA MOCA Part 2 (13.00 hours), ABA MOCA Patient Safety (11.25 hours), ABS CC (25.00 hours), CRNA: Nurse Anesthetist (25.00 hours), Non-Physician Attendance (25.00 hours), PA Patient Safety and Risk Credit (3.75 hours)

The 28^th Annual Jefferson Anesthesia Conference in Big Sky, Montana offers a diverse, comprehensive program with world-reknowned experts. The conference includes didactic lectures, pro/con debates, problem-based learning discussions, and a regional anesthesia, point-of-care ultrasound and airway workshop.

Learners will receive updates and information on current trends in ambulatory anesthesia, airway management, regional anesthesia, acute pain medicine, and pediatric anesthesia.

The conference will provide learners with the tools to implement enhanced recovery protocols in ambulatory surgery, utilize regional anesthesia in the ICU to improve outcomes as well as the perioperative impact of tranexamic acid. In a live workshop, learners will have hands-on experience with ultrasound-guided peripheral nerve and fascial plane blocks, point-of-care ultrasound as well as airway management techniques.

Updates in postdural puncture headache, PONV, airway management, and perioperative management of opioid use disorder will also be covered.

Successful Completion

 To successfully complete this activity, the required evaluation must be completed no later than Wednesday, February 28, 2024. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Utilize the most recent ASA airway guidelines in the approach to the difficult airway.
2. Apply effective enhanced recovery protocols in preventing failed same-day discharge in ambulatory surgery.
3. Implement comprehensive enhanced recovery protocols for ambulatory surgery.
4. Compare the effect of the most common drugs of abuse including fentanyl, xylazine, and cannabis on perioperative anesthetic care.
5. Develop an effective step-by-step approach to awake intubation.
6. Compare the benefits and pitfalls of double-lumen tubes versus bronchial blockers.
7. Recognize the most common adverse events that occur in the perioperative period secondary to modern drugs of abuse.
8. Develop methods to ensure health equity amongst patients receiving regional anesthesia and acute pain management.
9. Use inhalation anesthesia kinetic to clinical advantage during induction, maintenance, and emergence.
10. Translate the most recent recommendations on postoperative nausea and vomiting prophylaxis.
11. Explain the use of low flow anesthesia and control anesthetic depth.
12. Explain the most common complications of one-lung ventilation and the appropriate management.
13. Examine the literature for the benefits of regional anesthesia on respiratory function in patients with rib fracture.
14. Measure the value of regional anesthesia on improving analgesic outcomes in pediatric patients.
15. Compare the advantages and disadvantages of opioid vs opioid-free anesthesia.
16. Describe the use methadone intraoperatively as a component of the anesthetic management.
17. Discuss the increasing utilization of ambulatory surgery and the anesthetic implications.
18. Examine the potential pitfalls of running an inpatient and outpatient ketamine service.
19. Demonstrate the most effective approaches to prevent unrecognized esophageal intubation.
20. Examine the literature for the advantages and disadvantages of programmed intermittent bolus compared to continuous infusions in continuous peripheral nerve blocks.

Registration Type	Early Bird Fee	After January 1, 2024
Physician	$900	$975
CRNA	$850	$900
Resident/Fellow	$500	$550
Other Healthcare Provider	$500	$550

 

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 25.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Other Healthcare Professionals: This educational activity is designated for 25.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit
PA Patient Safety and Risk Credit: This education activity offers 3.75 PA Patient Safety and Risk credit. Qualifying sessions are identified on agenda.

MOCA 2.0®

Maintenance of Certification in Anesthesiology and MOCA are registered certification marks of the American Board of Anesthesiology.

 

AANA Credit
This program has been prior approved by the American Association of Nurse Anesthesiology for 25.00 Class A CE credits; Code Number 1043586; Expiration Date 2/8/2024.

Daily Credit

Date All Credit Types ABA MOCA Patient Safety Credit PA Patient Safety and Risk Credit
February 4  5.50 3.75 0.00
February 5 5.50 4.50 1.50
February 6 5.50 0.00 0.00
February 7 2.75 2.25 1.50
February 8 5.75 0.75 0.75

Cancellation Policy

Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. 

Submit refund requests to: Office of Continuing Professional Development Sidney Kimmel Medical College Jefferson Alumni Hall 1020 Locust Street, Suite M-5 Philadelphia, PA 19107

Or by email to [email protected] - please include the activity name in the subject line.

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. 

 Jefferson Release Policy

Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy

As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

 

Thank you to our In-Kind Supporters!

Ambu | Blink Device Company | Cook

Ge Healthcare | Mindray | Philips Healthcare | Verathon

Thank you to our Exhibitors!

Ambu | Blink Device Company | Central Main Healthcare | Eagle Pharmaceuticals | Heron Therapeutics

Medtronic | Merck | Mindray | Pajunk Medical Systems

 

---

Thank you for your interest in exhibiting at this in-person educational activity. BEFORE registering as an exhibitor, please contact Suzanne McCade either via email ([email protected]) or call (215) 955-7196.

• Exhibitor is not providing commercial support for this educational activity. Exhibitor is purchasing exhibit space.
• Exhibits are intended for informational purposes, products should not be sold through the exhibit hall.
• TJU and the exhibitor acknowledge and agree that the exhibitor may be subject to Section 6002 of the Affordable Care Act, which added Section 1128G to the Social Security Act, and its implementing regulations codified in 42 CFR 402 &403 (Collectively the Sunshine Act). Exhibiting companies are solely responsible for collecting any information about actions within their virtual exhibit space that constitutes a payment or transfer of value to a covered participant, which is required to reported under the Sunshine Act.
• Exhibitors may observe educational sessions but must refrain from participating in the activity.
• No recordings of the scientific sessions on behalf of the exhibitor's company is permitted.

• Prior to the deadline of Friday, January 19, 2024, a refund will be given minus a 10% administration fee.
• After Friday, January 19, 2024, no refund will be given.
• Exhibitors who are absent from the conference will not receive a refund.
• Exhibit cancellations must be made in writing. Send cancellation notice to [email protected] and include name of activity in subject line. 

Exhibit at this Event